227 related articles for article (PubMed ID: 21422963)
1. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China.
Wang CQ; Zhu QR
Pediatr Infect Dis J; 2011 Jul; 30(7):593-6. PubMed ID: 21422963
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China.
Zhang Q; Han F; Nie Q; Ren H; Zhang B; Liu Q; He Q; Shao Z
J Infect; 2011 Dec; 63(6):441-6. PubMed ID: 21864569
[TBL] [Abstract][Full Text] [Related]
4. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.
Rendi-Wagner P; Tobias J; Moerman L; Goren S; Bassal R; Green M; Cohen D
Vaccine; 2010 Apr; 28(19):3285-90. PubMed ID: 20226250
[TBL] [Abstract][Full Text] [Related]
5. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia.
Jõgi P; Oona M; Toompere K; Leedo S; Epstein J; Lutsar I
Vaccine; 2014 Sep; 32(41):5311-5. PubMed ID: 25093282
[TBL] [Abstract][Full Text] [Related]
7. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses.
Lai FY; Thoon KC; Ang LW; Tey SH; Heng D; Cutter JL; Phoon MC; Chow VT
Vaccine; 2012 May; 30(24):3566-71. PubMed ID: 22475863
[TBL] [Abstract][Full Text] [Related]
8. Estimated and reported incidence of pertussis in Estonian adults: A seroepidemiological study.
Jõgi P; Oona M; Toompere K; Lutsar I
Vaccine; 2015 Sep; 33(38):4756-61. PubMed ID: 26277068
[TBL] [Abstract][Full Text] [Related]
9. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.
Strebel P; Nordin J; Edwards K; Hunt J; Besser J; Burns S; Amundson G; Baughman A; Wattigney W
J Infect Dis; 2001 May; 183(9):1353-9. PubMed ID: 11294666
[TBL] [Abstract][Full Text] [Related]
10. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
Syed MA; Ahmed W; Naeem A; Bokhari H
J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of pertussis antibodies among adolescents in Israel.
Arav-Boger R; Ashkenazi S; Gdalevich M; Cohen D; Danon YL
Isr Med Assoc J; 2000 Feb; 2(2):174-7. PubMed ID: 10804947
[TBL] [Abstract][Full Text] [Related]
14. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.
Cherry JD; Chang SJ; Klein D; Lee M; Barenkamp S; Bernstein D; Edelman R; Decker MD; Greenberg DP; Keitel W; Treanor J; Ward JI
Clin Infect Dis; 2004 Dec; 39(11):1715-8. PubMed ID: 15578376
[TBL] [Abstract][Full Text] [Related]
16. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.
de Melker HE; Versteegh FG; Schellekens JF; Teunis PF; Kretzschmar M
J Infect; 2006 Aug; 53(2):106-13. PubMed ID: 16352342
[TBL] [Abstract][Full Text] [Related]
17. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.
Zhang Q; Zheng H; Liu M; Han K; Shu J; Wu C; Xu N; He Q; Luo H
BMC Infect Dis; 2012 Jun; 12():138. PubMed ID: 22892100
[TBL] [Abstract][Full Text] [Related]
18. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels.
Nagel J; de Graaf S; Schijf-Evers D
Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study.
Li X; Chen M; Zhang T; Li J; Zeng Y; Lu L
Hum Vaccin Immunother; 2015; 11(10):2434-9. PubMed ID: 26177302
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey.
Ozkal A; Sensoy G; Acuner C; Belet N; Güney AK
Turk J Pediatr; 2012; 54(1):15-9. PubMed ID: 22397036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
